Latest Hims News & Updates

See the latest news and media coverage for Hims. We track all announcements, press releases, and industry mentions in real time, all in one place.

Hims

Men's health telehealth provider

hims.com

Headquarters: San Francisco, United States
Founded year: 2017
Company type: Public company
Number of employees: 500–2,100

Last updated Today

Latest news about Hims

In short: Hims expanded its global footprint and weight-loss portfolio, despite facing legal challenges, a data breach, and intense market competition.

Company announcements

June 4 Hims

Hims names Dr. Anant Vinjamoori as Chief Medical Officer

Vinjamoori brings expertise in longevity medicine to lead clinical guidance across multiple health categories.

June 2 Hims

Hims completes acquisition of Eucalyptus, advancing its global position

It now has a leading presence across the US, UK, Australia, Canada, and Japan, aiming for $6.5B revenue by 2030.

May 21 Hims

Hims introduces generic semaglutide to Canadian customers

The medication offers affordable GLP-1 treatment for weight management and type 2 diabetes, with personalized care plans starting at $149/mo CAD.

May 18 Hims

Hims & Hers Health announces proposed convertible senior notes offering

The $300M offering aims to fund international expansion, including the Eucalyptus acquisition, and AI investments.

Media coverage

June 16 Seeking Alpha

Hims & Hers Enters A New Phase

Hims & Hers management targets at least $6.5B in revenue and $1.3B in adjusted EBITDA by 2030 through platform expansion. Read more on HIMS stock...

June 16 MSN

HIMS stock breaks above $30 ahead of upcoming FDA peptide review: Analysts eye next growth catalyst

Analysts and investors have turned their attention to a key regulatory meeting on peptides, a decision expected to trigger HIMS' next phase of growth.

June 16 Yahoo Finance

HIMS Stock Logs Best Day In 2 Months: Bull Sees Peptides Driving Up To $19B In Annual Revenue By 2030

Lupton projects the global peptide market could generate $250 billion to $380 billion in annual...

June 16 Yahoo Finance

Hims & Hers (HIMS) Climbs 12.5% as Obesity Market Momentum Builds

Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stocks Stealing the Spotlight from Wall Street Giants. Hims & Hers rallied by 12.49...

Never miss news about Hims

Track Hims and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Hims competitors & trending companies

Browse news for competitors to Hims and other trending companies.